MCID: HRP008
MIFTS: 25

Herpes Simiae

Categories: Rare diseases

Aliases & Classifications for Herpes Simiae

MalaCards integrated aliases for Herpes Simiae:

Name: Herpes Simiae 52
Monkey B Virus 52
B Virus 52

Classifications:



Summaries for Herpes Simiae

MalaCards based summary : Herpes Simiae, also known as monkey b virus, is related to herpesvirus simiae b virus infection and simian b virus infection. The drugs Mycophenolic acid and Tacrolimus have been mentioned in the context of this disorder. Affiliated tissues include liver, t cells and testes.

Related Diseases for Herpes Simiae

Diseases related to Herpes Simiae via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 751)
# Related Disease Score Top Affiliating Genes
1 herpesvirus simiae b virus infection 12.5
2 simian b virus infection 12.3
3 hepatitis b 12.1
4 hepatocellular carcinoma 11.8
5 hepatitis d 11.8
6 australia antigen 11.5
7 gianotti crosti syndrome 11.5
8 hepatitis 11.3
9 hepatitis b vaccine, response to 11.1
10 epidemic pleurodynia 11.1
11 liver cirrhosis 11.1
12 liver disease 11.0
13 hepatitis c virus 11.0
14 viral hepatitis 10.9
15 influenza 10.8
16 hepatitis c 10.7
17 glomerulonephritis 10.7
18 hepatitis a 10.6
19 membranous nephropathy 10.6
20 acute liver failure 10.6
21 immune deficiency disease 10.6
22 hepatoblastoma 10.6
23 human immunodeficiency virus type 1 10.6
24 b-cell lymphoma 10.5
25 viral infectious disease 10.5
26 syphilis 10.5
27 nephrotic syndrome 10.5
28 vaccinia 10.4
29 polyarteritis nodosa 10.4
30 fatty liver disease 10.4
31 lymphoma, hodgkin, classic 10.4
32 cholangiocarcinoma 10.4
33 diffuse large b-cell lymphoma 10.4
34 intrahepatic cholangiocarcinoma 10.4
35 lymphoma, non-hodgkin, familial 10.4
36 vasculitis 10.4
37 48,xyyy 10.4
38 hepatitis e 10.4
39 47,xyy 10.4
40 hepatic coma 10.4
41 severe combined immunodeficiency 10.4
42 myocarditis 10.4
43 human immunodeficiency virus infectious disease 10.4
44 end stage renal disease 10.4
45 hepatic encephalopathy 10.4
46 cytokine deficiency 10.4
47 autoimmune disease 10.3
48 immunoglobulin switch sequences 10.3
49 fatty liver disease, nonalcoholic 1 10.3
50 kidney disease 10.3

Graphical network of the top 20 diseases related to Herpes Simiae:



Diseases related to Herpes Simiae

Symptoms & Phenotypes for Herpes Simiae

Drugs & Therapeutics for Herpes Simiae

Drugs for Herpes Simiae (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 314)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Mycophenolic acid Approved Phase 4 24280-93-1 446541
2
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492 6473866
3
Atorvastatin Approved Phase 4 134523-00-5 60823
4
Neomycin Approved, Vet_approved Phase 4 1404-04-2 8378
5
Prednisolone phosphate Approved, Vet_approved Phase 4 302-25-0
6
Methylprednisolone Approved, Vet_approved Phase 4 83-43-2 6741
7
Methylprednisolone hemisuccinate Approved Phase 4 2921-57-5
8
Prednisolone Approved, Vet_approved Phase 4 50-24-8 5755
9 Prednisolone acetate Approved, Vet_approved Phase 4 52-21-1
10
Ledipasvir Approved Phase 4 1256388-51-8 67505836
11
Ribavirin Approved Phase 4 36791-04-5 37542
12
Zidovudine Approved Phase 4 30516-87-1 35370
13
Maraviroc Approved, Investigational Phase 4 376348-65-1 3002977
14
Epinephrine Approved, Vet_approved Phase 4 51-43-4 5816
15
Racepinephrine Approved Phase 4 329-65-7 838
16
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
17
Spironolactone Approved Phase 4 52-01-7, 1952-01-7 5833
18
Polyestradiol phosphate Approved Phase 4 28014-46-2
19
Carvedilol Approved, Investigational Phase 4 72956-09-3 2585
20
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
21
Peginterferon alfa-2b Approved Phase 4 99210-65-8, 215647-85-1
22
Lenvatinib Approved, Investigational Phase 4 417716-92-8
23
Sorafenib Approved, Investigational Phase 4 284461-73-0 216239 406563
24
Sofosbuvir Approved Phase 4 1190307-88-0 45375808
25
Velpatasvir Approved, Investigational Phase 4 1377049-84-7 67683363
26
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
27
Entecavir Approved, Investigational Phase 4 142217-69-4 153941
28
Clevudine Investigational Phase 4 163252-36-6
29
Prednisolone hemisuccinate Experimental Phase 4 2920-86-7
30 Lipid Regulating Agents Phase 4
31 Anticholesteremic Agents Phase 4
32 Hypolipidemic Agents Phase 4
33 Hormones Phase 4
34 Aluminum phosphate Phase 4
35 Anti-Inflammatory Agents Phase 4
36 Antineoplastic Agents, Hormonal Phase 4
37 Hormone Antagonists Phase 4
38 Methylprednisolone Acetate Phase 4
39 glucocorticoids Phase 4
40 Immunologic Factors Phase 4
41 Interferon alpha-2 Phase 4
42 interferons Phase 4
43 Interferon-alpha Phase 4
44 Ledipasvir, sofosbuvir drug combination Phase 4
45 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
46 Brewer's Yeast Phase 4
47 Epinephryl borate Phase 4
48 Hemagglutinins Phase 4
49 Estradiol 17 beta-cypionate Phase 4
50 Estradiol 3-benzoate Phase 4

Interventional clinical trials:

(show top 50) (show all 769)
# Name Status NCT ID Phase Drugs
1 Efficacy of Antiviral Therapy With Lamivudine or Entecavir After Radical Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma Unknown status NCT00768157 Phase 4 antiviral treatment (lamivudine or entecavir)
2 Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma Unknown status NCT01765231 Phase 4 Entecavir prophylaxis;Observation arm
3 The Observation Of Safety And Survival Of Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Combined With Anti-hepatitis B Virus Therapy Unknown status NCT01102335 Phase 4 Telbivudine
4 A Study Comparing the Effectiveness of Two Different Vaccination Schedules of the Combined Hepatitis A and B Vaccine(Twinrix Adult1440/20) Unknown status NCT00216229 Phase 4
5 Open Label, Multi-center, Randomized Study to Compare of Tacrolimus and Steroids in Combination With Mycophenolate Mofetil or Without Mycophenolate Mofetil in Liver Transplantation With Hepatitis B Virus(HBsAg) Positive Unknown status NCT02075242 Phase 4 Mycophenolate Mofetil;Tacrolimus
6 Investigator Initiated Study of Thymosin in HBV-related HCC Unknown status NCT02281266 Phase 4 thymalfasin;nucleoside analog (suggest to use entecavir)
7 Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy Unknown status NCT01768195 Phase 4 Entecavir prophylaxis
8 Hepatitis B Virus (HBV) Antibody (Anti-HBs) Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) Unknown status NCT01311674 Phase 4
9 PhaseIVstudy to Evaluate the Non-inferiority of Cavir®Tab. in Terms of Hepatitis B Virus(HBV)DNA Undetectability Comparing Baraclude® Tab. in Hepatitis B e Antigen(HBeAg)(+) Chronic Hepatitis B Patients Treated With Long-term Baraclude® Tab Unknown status NCT02523547 Phase 4 Cavir;Baraclude
10 Evaluation of the Immune Response After Vaccination Against Hepatitis B in Patients With Indolent Lymphoproliferative Disorders With no Treatment. Unknown status NCT01698866 Phase 4
11 Entecavir for Patients With Decompensated HBV-Related Cirrhosis:a Prospective Randomized Controlled Trial Unknown status NCT00663182 Phase 4 Entecavir
12 Telbivudine Renoprotective Effect in Patients With the HBV-related Liver Cirrhosis: a Randomized Controlled Trial Unknown status NCT01799486 Phase 4 Telbivudine;Enecavir;Adefovir
13 Phase IV Study of the Efficacy of Entecavir in Patients With Chronic Hepatitis B Virus Infection and Persistently Normal Alanine Aminotransferase Unknown status NCT01833611 Phase 4 Entecavir;placebo
14 The Effectiveness and Feasibility of Using Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug Test and Follow-up Study Unknown status NCT01312012 Phase 4 antiviral therapy
15 Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine Unknown status NCT01548326 Phase 4 Atorvastatin;placebo
16 Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients Unknown status NCT02327715 Phase 4 Emtricitabine
17 Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients Unknown status NCT02327689 Phase 4 Emtricitabine plus adefovir dipivoxil
18 Immunologic Response of Hepatitis B Single Dose Versus 3-dose Series in Previously Vaccinated HIV-infected Adults at Maharaj Nakorn Chiang Mai Hospital: A Randomized Controlled Trial Unknown status NCT03219203 Phase 4
19 Immunogenicity and Safety of 4- vs. 3-standard Doses HBV Vaccination in HIV-infected Adults With Isolated Anti-HBc Antibody Unknown status NCT03212911 Phase 4
20 Banlangen Granules Anti-seasonal Influenza Study: a Randomized, Double Blind, Positive and Placebo Controlled,Clinical Study. Unknown status NCT02232945 Phase 4 placebo of oseltamivir phosphate;oseltamivir phosphate;Banlangen (Radix Isatidis) granules;placebo of Banlangen(Radix Isatidis) granules
21 Prophylactic Use of Entecavir to Reduce Hepatitis Flare in Highly Viremic HBV Patients With Active Tuberculosis Receiving Anti-tuberculous Treatment Unknown status NCT01724723 Phase 4 entecavir (BARACLUDE®)
22 A Phase 4, Open-Label Study to Investigate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (Viread(R)) in Preventing Hepatocellular Carcinoma Recurrence in Chronic Hepatitis B Virus Infected Patients With Low Viral Load at Baseline Treated With Radiofrequency Ablation or Resection Unknown status NCT02308319 Phase 4 Tenofovir disoproxil fumarate
23 The Optimizing Treatment of Peginterferon Alpha in HBeAg-negative Chronic Hepatitis B Virus Patients With Low Level HBsAg Unknown status NCT02893124 Phase 4 peginterferon alfa
24 A Study of Efficacy and Safety of Telbivudine in Pregnancy for the Prevention of Perinatal Transmission of Hepatitis B Virus Infection Unknown status NCT00939068 Phase 4 Telbivudine
25 Efficacy and Safety of Combination Therapy With Entecavir, Peginterferon Alfa-2b and Immunomodulators in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients Unknown status NCT03332329 Phase 4 Entecavir;Granulocyte Macrophage Colony Stimulating Factor;Y peginterferon alfa-2b;HBV vaccine
26 Investigation on Antiviral Therapy of Peginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B Patients Based on Detection of Interferon Gene Mutation and Interferon Receptor Unknown status NCT02973646 Phase 4 Entecavir or Tenofovir;Peginterferon Alfa-2B
27 Randomized Study Comparing Nucleoside Analogues Plus Tenofovir and Nucleoside Analogues Plus Adefovir in Chronic Hepatitis B Patients With Suboptimal Response to Adefovir-based Combination Therapy Due to Nucleoside Analogues Resistance Unknown status NCT01595633 Phase 4 Switching from adefovir (10mg/day) to tenofovir (300mg/day)
28 The Therapy of Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis : A Multicenter, Prospective, Randomized, Controlled, Single-blind Trial. Unknown status NCT03062813 Phase 4 Tacrolimus &entecavir;placebo & entecavir
29 A Multicenter Study to Compare the Efficacy of a Prophylactic Use of Tenofovir by Duration for the Non-Hodgkin's Lymphoma Patients With Isolated Anti-HBc-positivity Who Will be Treated With Rituximab Based Chemotherapy Unknown status NCT02585947 Phase 4 Tenofovir
30 Sustained Off-treatment Response After HBeAg Loss in HBeAg-Pos Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues Unknown status NCT01911156 Phase 4 Continue NA treatment;Discontinue NA Treatment
31 Efficacies of Entecavir Add on Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 6 Months Treatment of Peginterferon Alpha 2a Unknown status NCT02368288 Phase 4 entecavir
32 Efficacies of Entecavir Add on HBeAg Negative Chronic Hepatitis B Patients With HBV DNA Load ≥1000 Copies/ml After 3 Months of Peginterferon Alpha 2a Treatment Unknown status NCT02365402 Phase 4 Entecavir
33 Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Hepatitis B e Antigen-positive Patients With Chronic Hepatitis B Unknown status NCT01906580 Phase 4 Peg-IFNα-2a;Entecavir
34 Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders Unknown status NCT01451801 Phase 4
35 A Prospective, Open-label, Multicenter Study of Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents Unknown status NCT02337127 Phase 4 Lamivudine
36 The Changes of CD8+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209037 Phase 4 Peginterferon Alfa-2a
37 The Changes of CD4+T Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B Unknown status NCT03209011 Phase 4 Peginterferon Alfa-2a
38 The Changes of Natural Killer Cells Frequency and Function During Pegylated Interferon α-2a and Nucleoside Analogues Treatment in Patients With Chronic Hepatitis B. Unknown status NCT03208998 Phase 4 Peginterferon Alfa-2a
39 Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation Unknown status NCT02417207 Phase 4 Entecavir combined long-term low-dose HBIG group intramuscular;Entecavir combined HBIG group short-term high-dose intravenous
40 Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related Hepatocellular Carcinoma With Low HBV DNA Replication: Effectiveness and Safety. A Prospective and Randomized Clinical Trial Unknown status NCT01894269 Phase 4 Lamivudine 100mg once daily; or Entecavir 0.5mg once daily.
41 A Multicenter, Open-label, Prospective Study to Evaluate Antiviral Efficacy and Safety of Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection Unknown status NCT01594905 Phase 4 Entecavir + Tenofovir (MDR group)
42 Randomized Trial of Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients Who Have Undergone Lamivudine/Adefovir Add-on Treatment Unknown status NCT01491295 Phase 4 Tenofovir disoproxil fumarate;Lamivudine plus adefovir
43 Randomized, Multicenter, Open -Label Clinical Trial to Study the Effect of Adding on Pegylated Interferon Therapy for Patients Diagnosed With Chronic Hepatitis B Showing Maintained Response While Receiving Ongoing Nucleotide Analogues Unknown status NCT02982837 Phase 4 PEG-IFN & Nucleos(t)tide analogues;Nucleos(t)tide analogues
44 An Open-label Rollover Study in Chinese Patients After Finishing a 3-year Randomize Trial for Chronic Hepatitis B With High Serum Viral Load But Mild Elevated Aminotransferase Unknown status NCT02463019 Phase 4 Tenofovir Disoproxil Fumarate
45 Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients. Unknown status NCT01101750 Phase 4
46 The Employing of the Bio-Hep-B PreS1/PreS2/S Hepatitis B Virus (HBV) Vaccine in New Born Babies From HBV Positive Palestinian Mothers Unknown status NCT01133184 Phase 4
47 A Pilot Study to Evaluate the Efficacy and Safety of Pegylated Interferon Alfa-2b Plus Ribavirin in the Treatment of Patients With Dual Chronic Hepatitis B and Delta Unknown status NCT00117533 Phase 4 pegylated IFN alfa-2b plus ribavirin
48 Efficacy of Systemic Glucocorticoid in the Treatment of Wheezing in Children Unknown status NCT00494624 Phase 4 prednisolone
49 A Phase lV Study to Evaluate the Long-term Safety and Efficacy of Clevudine in the Patients Chronically Infected With Hepatitis B Virus Completed NCT00558818 Phase 4 Clevudine
50 Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients Completed NCT00722332 Phase 4

Search NIH Clinical Center for Herpes Simiae

Genetic Tests for Herpes Simiae

Anatomical Context for Herpes Simiae

MalaCards organs/tissues related to Herpes Simiae:

40
Liver, T Cells, Testes, Kidney, B Cells, Brain, Bone Marrow

Publications for Herpes Simiae

Articles related to Herpes Simiae:

(show all 43)
# Title Authors PMID Year
1
A survey investigating the current practice of French health professionals regarding infection risk after monkey bites. 61
31828958 2020
2
Effective Prophylactic Therapy for Exposure to Monkey B Virus (Macacine alphaherpesvirus 1). 61
31810502 2020
3
Questioning the Extreme Neurovirulence of Monkey B Virus (Macacine alphaherpesvirus 1). 61
29666644 2018
4
Genome sequence variation among isolates of monkey B virus (Macacine alphaherpesvirus 1) from captive macaques. 61
28494342 2017
5
Optimized Expression, Purification of Herpes B Virus gD Protein in Escherichia coli, and Production of Its Monoclonal Antibodies. 61
27226876 2016
6
Genome sequence of a pathogenic isolate of monkey B virus (species Macacine herpesvirus 1). 61
24903602 2014
7
Role of the virion host shutoff protein in neurovirulence of monkey B virus (Macacine herpesvirus 1). 61
25341947 2014
8
Papiine herpesvirus 2 as a predictive model for drug sensitivity of Macacine herpesvirus 1 (monkey B virus). 61
25402179 2014
9
Characterization of a spontaneous drug-resistant mutant of monkey B virus (Macacine herpesvirus 1). 61
19609635 2009
10
Monkey B virus (Cercopithecine herpesvirus 1). 61
19793452 2008
11
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides. 61
17438061 2007
12
Primary mouse dermal fibroblast cell cultures as an in vitro model system for the differential pathogenicity of cross-species herpesvirus papio 2 infections. 61
17122896 2007
13
Neuropathogenesis of herpesvirus papio 2 in mice parallels infection with Cercopithecine herpesvirus 1 (B virus) in humans. 61
16432011 2006
14
The complete genome sequence of herpesvirus papio 2 (Cercopithecine herpesvirus 16) shows evidence of recombination events among various progenitor herpesviruses. 61
16414998 2006
15
Experimental infection of baboons (Papio cynocephalus anubis) with apathogenic and neurovirulent subtypes of herpesvirus papio 2. 61
16270898 2005
16
Temporal progression of viral replication and gross and histological lesions in Balb/c mice inoculated epidermally with Saimiriine herpesvirus 1 (SaHV-1). 61
15964589 2005
17
Validation of an enzyme-linked immunosorbent assay kit using herpesvirus papio 2 (HVP2) antigen for detection of herpesvirus simiae (B virus) infection in rhesus monkeys. 61
16089172 2005
18
DNA polymerase gene locus of Cercopithecine herpesvirus 1 is a suitable target for specific and rapid identification of viral infection by PCR technology. 61
15830148 2005
19
Clinicopathological characterization of monkey B virus (Cercopithecine herpesvirus 1) infection in mice. 61
15737347 2005
20
Complete genome sequence of cercopithecine herpesvirus 2 (SA8) and comparison with other simplexviruses. 61
15629785 2005
21
Use of herpesvirus papio 2 as an alternative antigen in immunoblotting assay for B virus diagnosis. 61
15187363 2004
22
Pathogenicity of different baboon herpesvirus papio 2 isolates is characterized by either extreme neurovirulence or complete apathogenicity. 61
14512523 2003
23
Sequence and genetic arrangement of the UL region of the monkey B virus (Cercopithecine herpesvirus 1) genome and comparison with the UL region of other primate herpesviruses. 61
12721804 2003
24
Quantitative real-time PCR for detection of monkey B virus (Cercopithecine herpesvirus 1) in clinical samples. 61
12711069 2003
25
Development of a green fluorescent protein reporter cell line to reduce biohazards associated with detection of infectious Cercopithecine herpesvirus 1 (monkey B virus) in clinical specimens. 61
12540167 2002
26
Detection of a unique genotype of monkey B virus (Cercopithecine herpesvirus 1) indigenous to native Japanese macaques (Macaca fuscata). 61
12540170 2002
27
Sequence and genetic arrangement of the U(S) region of the monkey B virus (cercopithecine herpesvirus 1) genome and comparison with the U(S) regions of other primate herpesviruses. 61
11773425 2002
28
Detection of B virus antibody in monkey sera using glycoprotein D expressed in mammalian cells. 61
11526123 2001
29
Retrospective analysis of an outbreak of B virus infection in a colony of DeBrazza's monkeys (Cercopithecus neglectus). 61
11200573 2000
30
Rapid discrimination of monkey B virus from human herpes simplex viruses by PCR in the presence of betaine. 61
10699035 2000
31
Herpesvirus papio 2: alternative antigen for use in monkey B virus diagnostic assays. 61
10638495 1999
32
The existence of differing monkey B virus genotypes with possible implications for degree of virulence in humans. 61
10090090 1999
33
Development of a competitive ELISA for detection of primates infected with monkey B virus (Herpesvirus simiae). 61
10029325 1999
34
Molecular evidence for distinct genotypes of monkey B virus (herpesvirus simiae) which are related to the macaque host species. 61
9765470 1998
35
Prevalence of Herpesvirus papio 2 in baboons and identification of immunogenic viral polypeptides. 61
9241626 1997
36
Serological survey for viral diseases in the Cayo Santiago rhesus macaque population. 61
2571176 1989
37
Sensitivity of equine herpesviruses 1 and 3 in vitro to a new nucleoside analogue, 9-[[2-hydroxy-1-(hydroxymethyl) ethoxy] methyl] guanine. 61
6307092 1983
38
A comparison of neutralization tests for the detection of antibodies to Herpesvirus simiae (monkey B virus). 61
6281573 1982
39
Recovery of herpes simiae (B virus) from both primary and latent infections in rhesus monkeys. 61
177038 1975
40
Latency of Herpes Simiae (B virus) in rabbits. 61
177039 1975
41
The isolation of monkey B virus (Herpesvirus simiae) from the trigeminal ganglia of a healthy seropositive rhesus monkey. 61
169266 1975
42
Heterogeneity in Herpes simiae (B virus) and some antigenic relationships in the herpes group. 61
4375486 1974
43
Animal infectivity of aerosols of monkey B virus. 61
13692428 1960

Variations for Herpes Simiae

Expression for Herpes Simiae

Search GEO for disease gene expression data for Herpes Simiae.

Pathways for Herpes Simiae

GO Terms for Herpes Simiae

Sources for Herpes Simiae

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....